Family Office Of America (FOFA) Free Cash Flow Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 133.09% |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 1,022.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,022.70% |
| Dec 31, 2025 | -386.74% |
| Sep 30, 2025 | -5.35% |
| Jun 30, 2025 | -117.09% |
| Mar 31, 2025 | -97.00% |
| Dec 31, 2024 | -313.87% |
| Sep 30, 2024 | 27.98% |
| Jun 30, 2024 | -424.04% |
| Mar 31, 2024 | 77.94% |
| Dec 31, 2023 | 92.16% |
| Sep 30, 2023 | 84.91% |
| Jun 30, 2023 | 104.95% |
| Mar 31, 2023 | 58.59% |
| Dec 31, 2022 | 41.87% |
| Sep 30, 2022 | 56.89% |